Neuroleptic malignant syndrome: successful treatment with bromocriptine.
D000293:Adolescent; D001480:Basal Ganglia Diseases / Q000188:drug therapy*; D001971:Bromocriptine / Q000627:therapeutic use*; D003402:Creatine Kinase / Q000097:blood; D006220:Haloperidol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006719:Homovanillic Acid / Q000097:blood; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy* / Q000201:enzymology; D010259:Paranoid Disorders / Q000188:drug therapy*; D011388:Prolactin / Q000097:blood; D000637:Transaminases / Q000097:blood
D001971:Bromocriptine; D011388:Prolactin; C033563:haloperidol decanoate; D000637:Transaminases; D003402:Creatine Kinase; D006220:Haloperidol; D006719:Homovanillic Acid